Currently out of the existing stock ratings of Catherine Ramsey Schulte, 104 are a BUY (79.39%), 27 are a HOLD (20.61%).

Catherine Ramsey Schulte

Work Performance Price Targets & Ratings Chart

Analyst Catherine Ramsey Schulte, currently employed at BAIRD, carries an average stock price target met ratio of 82% that have a potential upside of 22.15% achieved within 217 days.

Catherine Ramsey Schulte’s has documented 272 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ILMN, Illumina at 03-Dec-2025.

Wall Street Analyst Catherine Ramsey Schulte

Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS ).
The best stock recommendation documented was for ILMN (ILLUMINA) at 9/22/2020. The price target of $281 was fulfilled within 3 days with a profit of $19.8 (7.58%) receiving and performance score of 25.27.

Average potential price target upside

of $37.42 (8.8%) on TMO (THERMO FISHER SCIENTIFIC).
of $22.15 (38.05%) on NTRA (NATERA).
of $19.59 (6%) on WAT (WATERS).

A Agilent Technologies CSTL Castle Biosciences ILMN Illumina NSTG NanoString Technologies NTRA Natera TWST Twist Bioscience Corp TMO Thermo Fisher Scientific WAT Waters EXAS EXACT Sciences MRVI Maravai Lifesciences Holdings OXFD Oxford Immunotec Global PLC TECH Bio-Techne Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vijay Kumar (EVERCORE)